Evaluating Organ Systems in Lupus
LFA-REAL offers a straight-forward evaluation for lupus-affected organ systems, a study shows.
We've noticed that you're using an ad blocker
Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.
SUBSCRIBE: eNewsletter
LFA-REAL offers a straight-forward evaluation for lupus-affected organ systems, a study shows.
Anifrolumab, a type 1 interferon receptor antagonist, performs well in early trial, researchers show.
Patients sometimes insist on non-traditional therapies after a rheumatoid arthritis diagnosis. Their concerns shouldn't be ignored and instead, patients should be counseled on therapeutic options.
Facing a growing shortage, rheumatology is looking to attract the next generation of providers.
Retaining international medical students, addressing student loan debt, mentoring and case-based teaching could possibly reverse the rheumatologist shortage, analysis says.
In this Q&A we feature a conversation with Felipe Andrade, M.D., Ph.D., of the Johns Hopkins University School of Medicine in Baltimore.
The 2015 recommendations for PsA treatment highlight the importance of managing comorbidities and a patient-centered treatment approach.
Predictive modeling data can steer physicians toward making healthcare decisions that have positive outcomes for patients.
Q&A: Two experts discuss proposals for formal CVD risk calculators in RA and the need for long-term research to validate them.
Identifying quality indicators will be important under MACRA. Some say quality indicators are true measurements that reflect the standard of care.